+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Facial Fat Transfer Market by Donor Site (Abdomen, Flanks, Thigh), Type (Autologous, Microlipoinjection), Treatment Type, End Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4896587
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Facial Fat Transfer Market size was estimated at USD 1.69 billion in 2023, USD 1.90 billion in 2024, and is expected to grow at a CAGR of 12.56% to reach USD 3.87 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Facial Fat Transfer Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Facial Fat Transfer Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Facial Fat Transfer Market, highlighting leading vendors and their innovative profiles. These include Allergan PLC by AbbVie Inc., Anica Therapeutics Inc., Bausch Health Companies Inc. by Valeant Pharmaceuticals, Bioplus Co. Ltd., Bioxis Pharmaceuticals, Cytori Therapeutics, Inc., Emory Healthcare, Integra Lifesciences, Merz Pharma GmbH & Co KGaA, Ranfac Corp, Revance Therapeutics, Inc., Sanofi S.A., SciVision Biotech Inc., Sinclair Pharma, Stanford Health Care, and Suneva Medical.

Market Segmentation & Coverage

This research report categorizes the Facial Fat Transfer Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Donor Site
    • Abdomen
    • Flanks
    • Thigh
  • Type
    • Autologous
    • Microlipoinjection
  • Treatment Type
    • Dermal Fillers
    • Fat Injections
  • End Use
    • Clinics & Surgery Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Facial Fat Transfer Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Facial Fat Transfer Market?
  3. What are the technology trends and regulatory frameworks in the Facial Fat Transfer Market?
  4. What is the market share of the leading vendors in the Facial Fat Transfer Market?
  5. Which modes and strategic moves are suitable for entering the Facial Fat Transfer Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Facial Fat Transfer Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing importance for body aesthetics
5.1.1.2. Growing success rate of facial fat grafting procedures
5.1.1.3. Rising geriatric population and consumer awareness about health
5.1.2. Restraints
5.1.2.1. High cost of the procedure
5.1.3. Opportunities
5.1.3.1. Ongoing technological advancements and modernization in the production of paracetamol
5.1.3.2. Rising research and development activities in the healthcare sector
5.1.4. Challenges
5.1.4.1. Shortcomings of the procedure limiting mass adoption and uncertain regulations
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Facial Fat Transfer Market, by Donor Site
6.1. Introduction
6.2. Abdomen
6.3. Flanks
6.4. Thigh
7. Facial Fat Transfer Market, by Type
7.1. Introduction
7.2. Autologous
7.3. Microlipoinjection
8. Facial Fat Transfer Market, by Treatment Type
8.1. Introduction
8.2. Dermal Fillers
8.3. Fat Injections
9. Facial Fat Transfer Market, by End Use
9.1. Introduction
9.2. Clinics & Surgery Centers
9.3. Hospitals
10. Americas Facial Fat Transfer Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Facial Fat Transfer Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Facial Fat Transfer Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Allergan PLC by AbbVie Inc.
14.1.2. Anica Therapeutics Inc.
14.1.3. Bausch Health Companies Inc. by Valeant Pharmaceuticals
14.1.4. Bioplus Co. Ltd.
14.1.5. Bioxis Pharmaceuticals
14.1.6. Cytori Therapeutics, Inc.
14.1.7. Emory Healthcare
14.1.8. Integra Lifesciences
14.1.9. Merz Pharma GmbH & Co KGaA
14.1.10. Ranfac Corp
14.1.11. Revance Therapeutics, Inc.
14.1.12. Sanofi S.A.
14.1.13. SciVision Biotech Inc.
14.1.14. Sinclair Pharma
14.1.15. Stanford Health Care
14.1.16. Suneva Medical
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. FACIAL FAT TRANSFER MARKET RESEARCH PROCESS
FIGURE 2. FACIAL FAT TRANSFER MARKET SIZE, 2023 VS 2030
FIGURE 3. FACIAL FAT TRANSFER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. FACIAL FAT TRANSFER MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. FACIAL FAT TRANSFER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. FACIAL FAT TRANSFER MARKET DYNAMICS
FIGURE 7. FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2023 VS 2030 (%)
FIGURE 8. FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 12. FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2023 VS 2030 (%)
FIGURE 14. FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES FACIAL FAT TRANSFER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES FACIAL FAT TRANSFER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. FACIAL FAT TRANSFER MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. FACIAL FAT TRANSFER MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • Allergan PLC by AbbVie Inc.
  • Anica Therapeutics Inc.
  • Bausch Health Companies Inc. by Valeant Pharmaceuticals
  • Bioplus Co. Ltd.
  • Bioxis Pharmaceuticals
  • Cytori Therapeutics, Inc.
  • Emory Healthcare
  • Integra Lifesciences
  • Merz Pharma GmbH & Co KGaA
  • Ranfac Corp
  • Revance Therapeutics, Inc.
  • Sanofi S.A.
  • SciVision Biotech Inc.
  • Sinclair Pharma
  • Stanford Health Care
  • Suneva Medical

Methodology

Loading
LOADING...

Table Information